Bioanalytical Systems opened at $1.66 on Wednesday, Marketbeat.com reports. Bioanalytical Systems has a 1 year low of $1.76 and a 1 year high of $1.83. The company has a current ratio of 0.72, a quick ratio of 0.59 and a debt-to-equity ratio of 0.53.
Bioanalytical Systems (NASDAQ:BASI) last released its quarterly earnings data on Tuesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $5.94 million during the quarter. Bioanalytical Systems had a return on equity of 6.39% and a net margin of 2.35%.
About Bioanalytical Systems
Bioanalytical Systems, Inc provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through Contract Research Services and Research Products segments.
Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with MarketBeat.com's FREE daily email newsletter.